Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3120
-0.0100 (-3.11%)
Last updated: Aug 3, 2026, 3:02 PM CET

EPA:ALOPM Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.260.260.211.077.98-
Revenue Growth
26.01%26.13%-80.69%-86.57%--
Gross Profit
0.260.260.211.077.96-
Operating Income
5.715.71-7.81-9.94-1.61-
Net Income
5.485.48-7.21-8.09-0.23-
Earnings Per Share
0.300.30-0.40-0.49-0.01-
EPS Growth
-11.77%-----

Revenue by Segment

Fiscal YearTTMFY 2025
Period EndingDec '25 Dec '25
Taxable Services
0.110.11
Products Annexed Activities
0.160.16
Total
0.260.26

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.112.115.2710.3413.370
Total Debt
6.366.367.588.832.60
Net Cash (Debt)
-4.24-4.24-2.311.5110.770
Net Cash Growth
----85.98%1076987.80%-
Net Cash Per Share
-0.23-0.23-0.130.090.651.00

Cash Flow & CapEx

Fiscal YearTTMFY 2021FY 2020
Period EndingDec '21 Dec '21 Dec '20
Operating Cash Flow
-2.54-2.54-0.45
Capital Expenditures
-0.77-0.77-0.55
Free Cash Flow
-2.92-2.92-0.83
Free Cash Flow Growth
---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%99.80%-
Operating Margin
2185.54%2185.54%-3770.81%-927.44%-20.17%-
Pretax Margin
2110.78%2118.38%-3845.13%-919.05%-21.58%-
Profit Margin
2097.90%2105.49%-3313.36%-754.61%-2.90%-
FCF Margin
0.00%0.00%0.00%0.00%0.00%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.071.37----
Forward PE
-0.21----
PS Ratio
3.3829.1062.7328.163.54-